PD38-02 INTERNATIONAL PRESCRIBING RATES OF OPIOIDS AFTER ROBOTIC PROSTATECTOMY

Abstract

You have accessJournal of UrologyHealth Services Research: Quality Improvement & Patient Safety III (PD38)1 Sep 2021PD38-02 INTERNATIONAL PRESCRIBING RATES OF OPIOIDS AFTER ROBOTIC PROSTATECTOMY Emily C. Hacker, Michelle Yu, Maria M. Pere, Bruce L. Jacobs, and Benjamin J. Davies Emily C. HackerEmily C. Hacker More articles by this author , Michelle YuMichelle Yu More articles by this author , Maria M. PereMaria M. Pere More articles by this author , Bruce L. JacobsBruce L. Jacobs More articles by this author , and Benjamin J. DaviesBenjamin J. Davies More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000002048.02AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: The purpose of this study is to compare international opioid prescribing patterns for patients undergoing robotic assisted laparoscopic prostatectomy (RALP). To our knowledge, this is the first study to assess international opioid prescribing trends among urologists. METHODS: An anonymous Web-based survey assessing the frequency and quantity of opioid prescriptions for RALP was designed using Qualtrics software. The survey was distributed to urologists internationally via Twitter and email in early 2021. Prescribing patterns were analyzed based on country of practice in three groups: USA, Canada, and all other countries under the assumption that response rates would be lower in these countries. RESULTS: 145 participants from 21 countries completed the survey including the USA (56%), Greece (16%), Canada (9%), Israel (3.4%), Brazil (2%), the United Kingdom (2%), Germany (1.4%), and India (1.4%). 57% of respondents were attendings/consultants 32% residents, 10% fellows, and 2% advanced practice providers. The percentage of providers prescribing post-discharge opioids significantly differed between Canada, the United States, and other countries (85%, 63%, and 8%, respectively, p <0.0001). There was a significant difference between years of experience in those who provide opioids compared to those who do not (6.5 years vs 9.9 years, p=0.001). The average oral morphine equivalents (OME) provided in those who did prescribe opioids was greatest in Canada but was not significantly different between groups (mean OME: Canada 41mg, USA 35mg, all others 33mg; p=0.82). Attending physicians prescribed more OME than trainees (residents, fellows) on average (attending mean OME = 46 mg, trainee mean OME = 29 mg, p=0.0012). The most prescribed medication in the United States was oxycodone, hydromorphone in Canada, and tramadol in the rest of the world. CONCLUSIONS: Opioid prescriptions after prostatectomy are common in North America and uncommon in the rest of the world. Narcotic-free prostatectomies are still rare in North America and offer an opportunity for surgeons to decrease the pool of narcotics, and thus, reduce the risk of narcotic abuse. Source of Funding: Bruce L. Jacobs, MD MPH is supported in part by the Shadyside Hospital Foundation © 2021 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 206Issue Supplement 3September 2021Page: e661-e662 Advertisement Copyright & Permissions© 2021 by American Urological Association Education and Research, Inc.MetricsAuthor Information Emily C. Hacker More articles by this author Michelle Yu More articles by this author Maria M. Pere More articles by this author Bruce L. Jacobs More articles by this author Benjamin J. Davies More articles by this author Expand All Advertisement Loading ...